Investors thinking of buying a piece of Facebook after it goes public are hoping it will perform like Google, whose stock has risen 500 percent since its debut seven and a half years ago.
Shares of Amyris Inc. tumbled Friday, a day after the sustainable-energy company withdrew its production and cash flow targets and said it would look for additional financing to pay its bills.
Amgen and Celgene, looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts expect to be a major wave of biotech mergers... Read More